Supporting Data for Cannabidiol Effects on Prostate Cancer Models

Histology and experimental data supporting a thesis on the antitumor effects of cannabidiol (CBD) on prostate cancer. The dataset, authored by Salida Ali and last updated in April 2026, includes immunohistochemistry (IHC) data from in vitro and in vivo models. It is shared under a CC-BY-NC-4.0 license.

Use Cases

• Validate CBD's inhibition of testosterone biosynthesis based on steroidogenic enzyme expression data
• Analyze the epigenetic regulation of CEMIP and AR based on RNA sequencing and pathway enrichment results
• Evaluate nanoparticle drug delivery efficacy based on 3D spheroid model growth inhibition data
• Study hyaluronic acid metabolism remodeling via the HYAL2/CEMIP/ANXA1 axis mentioned in the description

Strengths

• Data is derived from both in vitro and in vivo models, providing multi-context evidence
• Includes results from RNA sequencing and pathway enrichment analyses
• License is clearly specified as CC-BY-NC-4.0

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Description metadata is limited; actual data quality requires manual inspection after download

Provenance

Source

figshare

Collection Method

Generated from functional and mechanistic studies in prostate cancer models, including RNA sequencing.

Time Range

Publication date suggests data generation likely occurred prior to 2026.

Freshness

Last updated 2026-04-29 06:01:40; freshness should be verified

Geography

Geographic coverage of the source models is not specified.